Discounted Cash Flow Rating

Sell

Return on Equity Rating

Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Strong Buy

Exponential Moving Average

Buy

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Buy

Wall Street Data Solutions Rating

Buy

A

Denali Therapeutics Inc. Common Stock (DNLI)

Biological Products, (no Disgnostic Substances)

https://www.denalitherapeutics.com

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

161 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

12/08/2017

Market Cap

3,337,176,150

Shares Outstanding

138,200,000

Weighted SO

138,196,848

Total Employees

N/A

Upcoming Earnings

08/13/2024

Similar Tickers

FIXX --.--%

STOK --.--%

BCEL --.--%

BDTX --.--%

FDMT --.--%

ASND --.--%

APLS --.--%

BGNE --.--%

AKRO --.--%

Beta

1.3920

Last Div

0.0000

Range

14.56-25.24

Chg

-0.3600

Avg Vol

1155032

Mkt Cap

3337176150

Exch

NASDAQ

Country

US

Phone

650 866 8548

DCF Diff

20.5996

DCF

-0.0696

Div Yield

0.0000

P/S

-10.9856

EV Multiple

-6.8033

P/FV

2.8373

Div Yield %

0.0000

P/E

-9.3779

PEG

-0.1583

Payout

0.0000

Current Ratio

12.4560

Quick Ratio

12.4560

Cash Ratio

1.0020

DSO

-1.6822

DIO

0.0000

Op Cycle

-1.6822

DPO

598.5691

CCC

-600.2512

Gross Margin

1.0280

Op Margin

1.6302

Pretax Margin

1.3814

Net Margin

1.3815

Eff Tax Rate

-0.0105

ROA

-0.2793

ROE

-0.3363

ROCE

-0.3468

NI/EBT

1.0001

EBT/EBIT

0.8474

EBIT/Rev

1.6302

Debt Ratio

0.0324

D/E

0.0351

LT Debt/Cap

0.0287

Total Debt/Cap

0.0340

Int Coverage

-23.4909

CF/Debt

-8.0173

Equity Multi

1.0833

Rec Turnover

-216.9829

Pay Turnover

0.6098

Inv Turnover

0.0000

FA Turnover

-4.1837

Asset Turnover

-0.2022

OCF/Share

-2.3151

FCF/Share

-2.3817

Cash/Share

5.3073

OCF/Sales

1.2867

FCF/OCF

1.0288

CF Coverage

-8.0173

ST Coverage

-50.2973

CapEx Coverage

-34.7771

Div&CapEx Cov

-34.7771

P/BV

2.8373

P/B

2.8373

P/S

-10.9856

P/E

-9.3779

P/FCF

-8.2994

P/OCF

-10.0687

P/CF

-10.0687

PEG

-0.1583

P/S

-10.9856

EV Multiple

-6.8033

P/FV

2.8373

DPS

0.0000

Latest Headlines (EST)

Zacks Investment Research Dec 26, 08:45 Fluor Corporation and Align Technology have been highlighted as Zacks Bull and Bear of the Day

Revenue Product Segmentation